HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter C Butler Selected Research

Amyloid (Amyloid Fibrils)

1/2023Efficacy of IAPP suppression in mouse and human islets by GLP-1 analogue conjugated antisense oligonucleotide.
1/2022IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes.
1/2018Proteasomal degradation of the histone acetyl transferase p300 contributes to beta-cell injury in a diabetes environment.
4/2016CHOP Contributes to, But Is Not the Only Mediator of, IAPP Induced β-Cell Apoptosis.
8/2014Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity.
9/2010The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity.
2/2010Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.
8/2009Dynamics of beta-cell turnover: evidence for beta-cell turnover and regeneration from sources of beta-cells other than beta-cell replication in the HIP rat.
4/2009Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced beta-cell endoplasmic reticulum stress.
5/2008Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter C Butler Research Topics

Disease

48Type 2 Diabetes Mellitus (MODY)
12/2023 - 01/2003
9Insulin Resistance
01/2023 - 08/2003
6Pancreatitis
07/2017 - 08/2006
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020 - 08/2006
5Hyperglycemia
01/2018 - 08/2003
5Neurodegenerative Diseases (Neurodegenerative Disease)
11/2016 - 05/2008
4Amyloid Plaque
01/2019 - 09/2010
4Alzheimer Disease (Alzheimer's Disease)
07/2015 - 02/2004
3Chronic Pancreatitis
01/2018 - 05/2012
3Proteostasis Deficiencies
11/2016 - 09/2010
3Neoplasms (Cancer)
07/2013 - 07/2011
3Hyperplasia
07/2013 - 07/2006
3Pancreatic Neoplasms (Pancreatic Cancer)
07/2013 - 07/2011
2Inflammation (Inflammations)
01/2018 - 07/2017
2Parkinson Disease (Parkinson's Disease)
07/2015 - 11/2009
2Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2013 - 07/2013
2Hypoglycemia (Reactive Hypoglycemia)
07/2013 - 07/2006
2Metaplasia
05/2012 - 07/2009
2Thyroid Neoplasms (Thyroid Cancer)
01/2012 - 07/2011
2Disease Progression
11/2009 - 07/2009
1Prediabetic State (Prediabetes)
01/2019
1Cystic Fibrosis (Mucoviscidosis)
09/2018
1Mitochondrial Diseases (Mitochondrial Disease)
11/2016
1Dehydration (Water Stress)
01/2016
1Brain Death (Brain Dead)
01/2016
1Metabolic Diseases (Metabolic Disease)
04/2015
1Weight Loss (Weight Reduction)
07/2013
1Papillary Thyroid Cancer
01/2012
1Papillary Carcinoma
01/2012
1Retinoblastoma (Glioblastoma, Retinal)
08/2011
1Infections
09/2008
1Insulinoma
01/2008
1Glucose Intolerance
08/2006
1Morbid Obesity
07/2006
1Genetic Predisposition to Disease (Genetic Predisposition)
02/2004
1Diabetes Mellitus
08/2003

Drug/Important Bio-Agent (IBA)

30Islet Amyloid PolypeptideIBA
12/2023 - 07/2003
21Amyloid (Amyloid Fibrils)IBA
01/2023 - 07/2003
18Insulin (Novolin)FDA Link
01/2023 - 08/2003
12Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2004
11Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2003
7Hormones (Hormone)IBA
09/2018 - 11/2009
5Glucagon (Glukagon)FDA Link
01/2018 - 04/2006
4Glucagon-Like Peptide 1 (GLP 1)IBA
10/2016 - 01/2012
2UbiquitinIBA
12/2023 - 01/2011
2Proteasome Endopeptidase Complex (Proteasome)IBA
12/2023 - 01/2011
2Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2007
2RNA (Ribonucleic Acid)IBA
01/2020 - 11/2018
2CytokinesIBA
01/2020 - 01/2018
2Chromogranin AIBA
09/2018 - 01/2018
2IncretinsIBA
10/2013 - 07/2013
2Peptides (Polypeptides)IBA
04/2013 - 07/2003
2Glucagon-Like Peptide-1 ReceptorIBA
05/2012 - 01/2012
2Exenatide (Byetta)FDA Link
05/2012 - 07/2011
2Sitagliptin Phosphate (Januvia)FDA Link
07/2011 - 07/2009
2Amyloidogenic ProteinsIBA
01/2010 - 05/2008
1FructoseIBA
01/2020
1Lactic Acid (Lactate)FDA LinkGeneric
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1Hypoxia-Inducible Factor 1IBA
01/2020
1ChromograninsIBA
05/2017
1CalpainIBA
11/2016
1CCAAT-Enhancer-Binding ProteinsIBA
04/2016
1Ethanol (Ethyl Alcohol)IBA
01/2016
1AutoantibodiesIBA
01/2016
1TolueneIBA
01/2016
1Protein AggregatesIBA
07/2015
1Insulysin (Insulin-Degrading Enzyme)IBA
08/2014
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
07/2013
1Glucagon-Like Peptides (Enteroglucagon)IBA
05/2012
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2012
1E2F Transcription FactorsIBA
08/2011
1HeterochromatinIBA
08/2011
1Chromobox Protein Homolog 5IBA
08/2011
1Small Interfering RNA (siRNA)IBA
04/2011
1Cyclin-Dependent Kinase 5IBA
04/2011
1CurcuminIBA
09/2010
1CalciumIBA
01/2010
1Peptide Hydrolases (Proteases)FDA Link
01/2010
1alpha-SynucleinIBA
11/2009
1Blood Glucose (Blood Sugar)IBA
07/2009
1Metformin (Glucophage)FDA LinkGeneric
07/2009
1TunicamycinIBA
01/2008
1AntibodiesIBA
01/2008
1IsotopesIBA
08/2006
1AcidsIBA
06/2004
1Amyloid beta-PeptidesIBA
02/2004

Therapy/Procedure

9Therapeutics
07/2017 - 07/2011
3Pancreatectomy
08/2006 - 07/2006
2Islets of Langerhans Transplantation
01/2007 - 08/2006
1Catheters
09/2008
1Investigational Therapies (Experimental Therapy)
08/2006
1Gastric Bypass (Roux-en-Y Gastric Bypass)
07/2006